SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping

Abstract Recently, the pharmaceutical industry has heavily emphasized phenotypic drug discovery (PDD), which relies primarily on knowledge about phenotype changes associated with diseases. Traditional Chinese medicine (TCM) provides a massive amount of information on natural products and the clinical symptoms they are used to treat, which are the observable disease phenotypes that are crucial for clinical diagnosis and treatment. Curating knowledge of TCM symptoms and their relationships to herbs and diseases will provide both candidate leads and screening directions for evidence-based PDD programs. Therefore, we present SymMap, an integrative database of traditional Chinese medicine enhanced by symptom mapping. We manually curated 1717 TCM symptoms and related them to 499 herbs and 961 symptoms used in modern medicine based on a committee of 17 leading experts practicing TCM. Next, we collected 5235 diseases associated with these symptoms, 19 595 herbal constituents (ingredients) and 4302 target genes, and built a large heterogeneous network containing all of these components. Thus, SymMap integrates TCM with modern medicine in common aspects at both the phenotypic and molecular levels. Furthermore, we inferred all pairwise relationships among SymMap components using statistical tests to give pharmaceutical scientists the ability to rank and filter promising results to guide drug discovery. The SymMap database can be accessed at http://www.symmap.org/ and https://www.bioinfo.org/symmap.

[1]  Chen Kk A pharmacognostic and chemical study of ma huang (Ephedra vulgaris var. helvetica). 1925. , 2012 .

[2]  D. Altman,et al.  Multiple significance tests: the Bonferroni method , 1995, BMJ.

[3]  Y. Tu The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine , 2011, Nature Medicine.

[4]  R. Fisher On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2018, Journal of the Royal Statistical Society Series A (Statistics in Society).

[5]  Jane Qiu,et al.  Traditional medicine: A culture in the balance , 2007, Nature.

[6]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[7]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[8]  D C Swinney,et al.  Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines , 2013, Clinical pharmacology and therapeutics.

[9]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[10]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[11]  Cynthia Brandt,et al.  Research Paper: UMLS Concept Indexing for Production Databases: A Feasibility Study , 2001, J. Am. Medical Informatics Assoc..

[12]  F. Dhombres,et al.  Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end users , 2012, Human mutation.

[13]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[14]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[15]  K K Chen A pharmacognostic and chemical study of ma huang (Ephedra vulgaris var. helvetica). 1925. , 2012, Journal of the American Pharmacists Association : JAPhA.

[16]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[17]  Tatiana A. Tatusova,et al.  Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..

[18]  Peter L. Elkin,et al.  UMLS Concept Indexing for Production Databases: A Feasibility Study , 2001, J. Am. Medical Informatics Assoc..

[19]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[20]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[21]  Fernando Fernandez-Llimos,et al.  Quality of pharmacy-specific Medical Subject Headings (MeSH) assignment in pharmacy journals indexed in MEDLINE. , 2015, Research in social & administrative pharmacy : RSAP.

[22]  David J Newman,et al.  Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.

[23]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[24]  Peer Bork,et al.  The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..

[25]  R. Fisher On the Interpretation of χ 2 from Contingency Tables , and the Calculation of P Author , 2022 .

[26]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[27]  Aining Yin,et al.  Ontology development for unified traditional Chinese medical language system , 2004, Artif. Intell. Medicine.

[28]  Yan Shi,et al.  TCMID 2.0: a comprehensive resource for TCM , 2017, Nucleic Acids Res..

[29]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .